Suppression of tumor metastasis by blockade of transforming growth factor β signaling in bone marrow cells through a retroviral-mediated gene therapy in mice

Ali H. Shah, William B. Tabayoyong, Shilajit D. Kundu, Seong Jin Kim, Luk Van Parijs, Victoria C. Liu, Eugene Kwon, Norman M. Greenberg, Chung Lee

Research output: Contribution to journalArticle

56 Scopus citations

Abstract

Transforming growth factor B (TGF-β) is a potent immunosuppressive cytokine that is frequently associated with mechanisms of tumor escape from immunosurveillance. We report that transplantation of murine bone marrow (BM) expressing a dominant-negative TGF-β type II receptor (TβRIIDN) leads to the generation of mature leukocytes capable of a potent antitumor response in vivo. Hematopoietic precursors in murine BM from donor mice were rendered insensitive to TGF-β via retroviral expression of the TβRIIDN construct and were transplanted in C57BL/6 mice before tumor challenge. After i.v. administration of 5 × 105 B16-F10 murine melanoma cells into TβRIIDN-BM transplanted recipients, survival of challenged mice at 45 days was 70% (7 of 10) versus 0% (0 of 10) for vector-control treated mice, and surviving TβRIIDN-BM mice showed a virtual absence of metastatic lesions in the lung. We also investigated the utility of the TGF-β-targeted approach in a mouse metastatic model of prostate cancer, TRAMP-C2. Treatment of male C57BL/6 mice with TβRIIDN-BM resulted in the survival of 80% (4 of 5) of recipients versus 0% (0 of 5) in green fluorescent protein-BM recipients or wild-type controls. Cytolytic T-cell assays indicate that a specific T-cell response against B16-F10 cells was generated in the TβRIIDN-BM-treated mice, suggesting that a gene therapy approach to inducing TGF-β insensitivity in transplanted BM cells may be a potent anticancer therapy.

Original languageEnglish (US)
Pages (from-to)7135-7138
Number of pages4
JournalCancer research
Volume62
Issue number24
StatePublished - Dec 15 2002

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Suppression of tumor metastasis by blockade of transforming growth factor β signaling in bone marrow cells through a retroviral-mediated gene therapy in mice'. Together they form a unique fingerprint.

  • Cite this

    Shah, A. H., Tabayoyong, W. B., Kundu, S. D., Kim, S. J., Van Parijs, L., Liu, V. C., Kwon, E., Greenberg, N. M., & Lee, C. (2002). Suppression of tumor metastasis by blockade of transforming growth factor β signaling in bone marrow cells through a retroviral-mediated gene therapy in mice. Cancer research, 62(24), 7135-7138.